JnJ CEO declines to appear at US congressional hearing on carcinogen in baby powder Medical Dialogues Bureau10 Dec 2019 9:15 AM ISTJnJ spokesman Ernie Knewitz said that the subcommittee had rejected the company's offers to send a talc testing expert or a JnJ executive in charge of...
Grifols Alzheimers trial shows positive results Medical Dialogues Bureau10 Dec 2019 9:00 AM ISTThe latest results strengthen Grifols' research on plasma protein replacement therapies, the company said.New Delhi: Spain's Grifols said on Friday...
Sun Pharma arm-SPARC updates on Paclitaxel Injection Concentrate for Suspension litigation Farhat Nasim9 Dec 2019 3:56 PM IST"Abraxis Biosciences LLC has dismissed the patent infringement complaint filed against Sun Pharma Advanced Research Co Ltd regarding SPARC's New Drug...
Solara Active Pharma names Bharath R Sesha as new CEO Farhat Nasim9 Dec 2019 3:15 PM IST"The Board of Directors, on the recommendation of Nomination and Remuneration Committee, have appointed Bharath R Sesha as Chief Executive Officer of...
Amgen biosimilar to JnJ arthritis drug Remicade gets USFDA approval Medical Dialogues Bureau9 Dec 2019 1:00 PM ISTAmgen Inc's biosimilar, Avsola, has the same chemical components, dosage form and strength as Remicade and would treat a range of autoimmune...
GAVI to invest USD 178 million for creating Ebola vaccine stockpile Farhat Nasim9 Dec 2019 9:30 AM ISTSince the latest outbreak in Congo was identified last August, health officials have immunised more than 255, 000 people with a recently licensed...
Bristol-Myers, bluebird cancer therapy meets goal in mid-stage trial Medical Dialogues Bureau9 Dec 2019 9:15 AM ISTThe study evaluated the efficacy and safety of the therapy, Ide-cel, in patients who had received three prior treatments for multiple myeloma, a...
Bayer, plaintiffs to postpone more glyphosate lawsuits for settlement talks Medical Dialogues Bureau9 Dec 2019 9:00 AM ISTBayer acquired the weed killer brands last year as part of a $63 billion takeover of Monsanto, has ruled out pulling the products from the U.S....
Dabur eyes to acquire firms, expand in rural India with Rs 3500 crore war chest: Report Farhat Nasim8 Dec 2019 9:45 AM IST“We have a ready war chest available to acquire companies,” Malhotra said, adding that Dabur has reserves of up to 35 billion rupees ($490 million)....
Generic versions of Novartis blockbuster MS drug Gilenya gets USFDA green flag Medical Dialogues Bureau8 Dec 2019 9:38 AM ISTThe approval allows HEC Pharm Co Ltd, Biocon Ltd and Sun Pharmaceutical Industries Ltd to produce Gilenya for the treatment of relapsing forms of MS...
AstraZeneca-Merck cancer drug Lynparza wins approval in China Medical Dialogues Bureau8 Dec 2019 9:20 AM ISTLynparza is currently approved in 65 countries for the maintenance treatment of platinum-sensitive relapsed ovarian cancer, AstraZeneca and Merck...
GSK seeks USFDA approval for investigational HIV treatment Fostemsavir Medical Dialogues Bureau8 Dec 2019 9:15 AM ISTGSK Plc's Fostemsavir is being developed for use in combination with other antiretroviral agents in adults who have been previously taken treatments...
